Basic Information
BociMed, as a drug research and development and production service (CRO/CDMO) company focused on improved new drugs, innovative drugs, and high-end formulations, is committed to building an international and cutting-edge pharmaceutical R&D and innovation platform. With extensive development experience in the fields of oncology, cardiovascular, immunology, neurology, and psychiatry, BociMed also possesses rich professional expertise and innovative technological advantages in advanced formulation technologies (such as oral sustained-release and controlled-release, oral solid solubilization, long-acting injections, liquids, semi-solids, etc.).
BociMed
Shanghai,China
101~500 people
September 19, 2012
jiajun.song@bocimed.com

